Movement Alert｜BIOCYTOGEN-B Intraday Decline 5.08%, CMB International Substantially Reduces Stake as Biotech Sector Under Pressure

Market Focus07-28

On July 28, BIOCYTOGEN-B fell 5.08% in regular trading, trading at 51.15 HKD/share, with turnover of 12.7225 million HKD.

On the news front, CMB International Financial Holdings and its affiliates — CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — collectively sold 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, their combined long position decreased from 11.94% to 10.95%. The concentrated reduction by a major shareholder weighed on market confidence.

Within the Biotechnology sector, the broader segment traded weak. Among individual stocks, LEADS BIOLABS-B down 3.62%, KEYMED BIO-B down 4.19%, AKESO down 2.08%, BEIGENE down 1.30%, INNOVENT BIO down 0.78%. Meanwhile, E Fund Management increased its holding by 181,000 shares on July 15 at approximately 56.60 HKD per share, providing partial offsetting support.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137667583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 10:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137667583","market":"us","top_or_hot":-1,"title":"Movement Alert｜BIOCYTOGEN-B Intraday Decline 5.08%, CMB International Substantially Reduces Stake as Biotech Sector Under Pressure","media":"Market Focus","content":"<p><p>On July 28, BIOCYTOGEN-B fell 5.08% in regular trading, trading at 51.15 HKD/share, with turnover of 12.7225 million HKD.</p><p>On the news front, CMB International Financial Holdings and its affiliates — CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — collectively sold 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, their combined long position decreased from 11.94% to 10.95%. The concentrated reduction by a major shareholder weighed on market confidence.</p><p>Within the Biotechnology sector, the broader segment traded weak. Among individual stocks, LEADS BIOLABS-B down 3.62%, KEYMED BIO-B down 4.19%, AKESO down 2.08%, BEIGENE down 1.30%, INNOVENT BIO down 0.78%. Meanwhile, E Fund Management increased its holding by 181,000 shares on July 15 at approximately 56.60 HKD per share, providing partial offsetting support.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BIOCYTOGEN-B Intraday Decline 5.08%, CMB International Substantially Reduces Stake as Biotech Sector Under Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BIOCYTOGEN-B Intraday Decline 5.08%, CMB International Substantially Reduces Stake as Biotech Sector Under Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, BIOCYTOGEN-B fell 5.08% in regular trading, trading at 51.15 HKD/share, with turnover of 12.7225 million HKD.</p><p>On the news front, CMB International Financial Holdings and its affiliates — CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — collectively sold 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, their combined long position decreased from 11.94% to 10.95%. The concentrated reduction by a major shareholder weighed on market confidence.</p><p>Within the Biotechnology sector, the broader segment traded weak. Among individual stocks, LEADS BIOLABS-B down 3.62%, KEYMED BIO-B down 4.19%, AKESO down 2.08%, BEIGENE down 1.30%, INNOVENT BIO down 0.78%. Meanwhile, E Fund Management increased its holding by 181,000 shares on July 15 at approximately 56.60 HKD per share, providing partial offsetting support.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"","article_id":"1137667583","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137667583","pubTimestamp":1785206430,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, BIOCYTOGEN-B fell 5.08% in regular trading, trading at 51.15 HKD/share, with turnover of 12.7225 million HKD.On the news front, CMB International Financial Holdings and its affiliates —...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02315":"百奥赛图-B"},"translate_title":"走势预警|BIOCYTOGEN-B盘中跌5.08%，招银国际大幅减持，生物科技板块承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"On July 28, BIOCYTOGEN-B fell 5.08% in regular trading, trading at 51.15 HKD/share, with turnover of 12.7225 million HKD.On the news front, CMB International Financial Holdings and its affiliates — CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — collectively sold 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, their combined long position decreased from 11.94% to 10.95%. The concentrated reduction by a major shareholder weighed on market confidence.Within the Biotechnology sector, the broader segment traded weak. Among individual stocks, LEADS BIOLABS-B down 3.62%, KEYMED BIO-B down 4.19%, AKESO down 2.08%, BEIGENE down 1.30%, INNOVENT BIO down 0.78%. Meanwhile, E Fund Management increased its holding by 181,000 shares on July 15 at approximately 56.60 HKD per share, providing partial offsetting support.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137667583","isCrawlerRequest":true}